FDA
-
-
-
-
-
-
-
Molecular Templates Announces the FDA Removal of Partial Clinical Hold in the Phase 1 Clinical Trial for MT-0169 and Focuses on Extramedullary Myeloma
-
-
-
-
-
-
-
Molecular Templates, Inc. Reports Fourth Quarter 2021 Financial Results
-
-
-
-
-
-
-
Molecular Templates, Inc. Reports Fourth Quarter 2020 Financial Results
-
-
-
-
-
-
-
Pre-Open Movers 11/21: (AMTD) (PLAN) (SCHW) Higher; (CUB) (BJ) (OPTN) Lower (more...)
-
-
-
-
-
-
-
Molecular Templates, Inc. Reports Third Quarter 2017 Financial Results
325,889 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

